跳至主要内容
临床试验/JPRN-UMIN000010895
JPRN-UMIN000010895已完成未知

The study for the efficacy of amlodipine/atorvastatin combination drug in patients with type 2 diabetes complicated with hypertention and hypercholestrolemia. - Caduet clinical research

Kanazawa Medical University Diabetes and Endocrinology0 个研究点目标入组 240 人开始时间: 2013年6月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients whose systolic blood pressure is more than 180mmHg and diastolic blood pressure is more than 110mmHg and whose blood pressure are not well-controlled and considered to add or increase the dose of hypertensive drugs druing this study. 2) Secondry hypertention patiebs. 3) Familial hypercholesterolemia patients. 4) Patients with secondary prevention who developed cardiovascular events,such as acute myocardial infarction and cerebral infarction in the past. 5) Patients with severe heart failure patients. 6) Patients with severe arrhythmias. 7) eGFR is less than 40ml/min/1.73 square meters. 8) Patients with advanced liver failure. 9) Patients with active malignancy. 10)Patients during administration of immunosuppressants or steroid. 11) Women who are pregnant or possibly pregnant or wish to pregnant or lactating. 12)Patients with allergy or contraindication to test drug. 13) Intellectually or mentally disabled patients who are impossible to agree or with suspected ability to agree. 14) Patients judged not suitable by the attending physician.

研究者

发起方
Kanazawa Medical University Diabetes and Endocrinology

相似试验